Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis - Top-Institutions - MDSpire

Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis

  • By

  • Shunli Liu

  • Yan Wang

  • Yang Cao

  • Huiling Song

  • Zhiqing Tian

  • Xue Li

  • Lan Huang

  • July 2, 2026

  • 0 min

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Cincinnati Children’s Hospital Medical Center
    Cincinnati Children’s Hospital Medical Center

    Cincinnati, Ohio

    Key Differentiators

    • Pediatrics

  • #2

    Texas Children’s Hospital
    Texas Children’s Hospital

    Houston, Texas

    Key Differentiators

    • Pediatrics

Original Source(s)

Efficacy and safety of monoclonal antibodies against respiratory syncytial virus disease in premature infants: a systematic review and network meta-analysis

  • by Shunli Liu, Yan Wang, Yang Cao, Huiling Song, Zhiqing Tian, Xue Li, Lan Huang

  • July 2, 2026

Related Content

Patient characteristics, vital signs and tcpCO2 dynamics significantly influence tcpCO2 accuracy in extremely preterm infants: an observational study

Limbic System Microstructure in Neonates With Antenatal Opioid Exposure

Psychiatric and neurological predictors of early ADHD medication discontinuation across the lifespan: a multinational study